niacinamide has been researched along with Fatty Liver in 18 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, increased hepatic microvasculatures compliance-related improved buffering effect of portal vein to acute mannitol infusion was associated with decreased circulating nitric oxide and aldosterone, plasma volume expansion (dye dilution method), splanchnic blood pooling ((99 m) Tc-RBC SPECT/PET/CT scans), peripheral hypotension, portal hypertension and ascites in brivanib and sorafenib-treated NASH-cirrhotic rats." | 3.80 | Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. ( Hsieh, YC; Huang, YT; Lee, FY; Lee, KC; Lee, PC; Lee, WP; Lin, HC; Liu, RS; Tan, TW; Yang, YY; Yeh, YC, 2014) |
| "Deletion of glycine N-methyltransferase (GNMT), the main gene involved in liver S-adenosylmethionine (SAM) catabolism, leads to the hepatic accumulation of this molecule and the development of fatty liver and fibrosis in mice." | 3.76 | Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide. ( Calvisi, DF; Embade, N; Esteller, M; Fernández-Ramos, D; Frades, I; Fraga, MF; Julve, J; Lu, SC; Luka, Z; Martínez-Chantar, ML; Martínez-López, N; Mato, JM; Rodríguez, J; Rodríguez-Millán, E; Torres, L; Varela-Rey, M; Wagner, C; Woodhoo, A, 2010) |
| "In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes." | 1.40 | Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. ( Alhonen, L; Asara, JM; Banks, AS; Bhanot, S; Cen, Y; Gong, F; Kahn, BB; Kong, D; Kraus, D; Monia, BP; Peroni, OD; Pirinen, E; Puigserver, P; Pulinilkunnil, TC; Rodgers, JT; Sauve, AA; Wang, YC; Yang, Q; Zhang, L, 2014) |
| "Sorafenib was acutely administered to NASH rats with IR liver injury that were or were not chronically pretreated with the Rho-kinase-specific inhibitor fasudil." | 1.38 | Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis. ( Chan, CC; Huang, YT; Lee, KC; Lee, TY; Lin, HC; Yang, YY; Yeh, YC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Q | 1 |
| Wang, J | 1 |
| Griffiths, A | 1 |
| Lee, SM | 1 |
| Iyamu, ID | 1 |
| Huang, R | 1 |
| Cordoba-Chacon, J | 1 |
| Song, Z | 1 |
| Diani-Moore, S | 1 |
| Shoots, J | 1 |
| Singh, R | 1 |
| Zuk, JB | 1 |
| Rifkind, AB | 1 |
| Mitchell, SJ | 1 |
| Bernier, M | 1 |
| Aon, MA | 1 |
| Cortassa, S | 1 |
| Kim, EY | 1 |
| Fang, EF | 1 |
| Palacios, HH | 1 |
| Ali, A | 1 |
| Navas-Enamorado, I | 1 |
| Di Francesco, A | 1 |
| Kaiser, TA | 1 |
| Waltz, TB | 1 |
| Zhang, N | 1 |
| Ellis, JL | 1 |
| Elliott, PJ | 1 |
| Frederick, DW | 1 |
| Bohr, VA | 1 |
| Schmidt, MS | 1 |
| Brenner, C | 1 |
| Sinclair, DA | 1 |
| Sauve, AA | 3 |
| Baur, JA | 1 |
| de Cabo, R | 1 |
| Fan, R | 1 |
| Cui, J | 1 |
| Ren, F | 1 |
| Wang, Q | 1 |
| Huang, Y | 1 |
| Zhao, B | 1 |
| Wei, L | 1 |
| Qian, X | 1 |
| Xiong, X | 1 |
| Komatsu, M | 1 |
| Kanda, T | 1 |
| Urai, H | 1 |
| Kurokochi, A | 1 |
| Kitahama, R | 1 |
| Shigaki, S | 1 |
| Ono, T | 1 |
| Yukioka, H | 1 |
| Hasegawa, K | 1 |
| Tokuyama, H | 1 |
| Kawabe, H | 1 |
| Wakino, S | 1 |
| Itoh, H | 1 |
| Yang, YY | 2 |
| Liu, RS | 1 |
| Lee, PC | 1 |
| Yeh, YC | 2 |
| Huang, YT | 2 |
| Lee, WP | 1 |
| Lee, KC | 2 |
| Hsieh, YC | 1 |
| Lee, FY | 1 |
| Tan, TW | 1 |
| Lin, HC | 2 |
| Kraus, D | 1 |
| Yang, Q | 1 |
| Kong, D | 1 |
| Banks, AS | 1 |
| Zhang, L | 1 |
| Rodgers, JT | 1 |
| Pirinen, E | 1 |
| Pulinilkunnil, TC | 1 |
| Gong, F | 1 |
| Wang, YC | 1 |
| Cen, Y | 1 |
| Asara, JM | 1 |
| Peroni, OD | 1 |
| Monia, BP | 1 |
| Bhanot, S | 1 |
| Alhonen, L | 1 |
| Puigserver, P | 1 |
| Kahn, BB | 1 |
| Gariani, K | 1 |
| Menzies, KJ | 1 |
| Ryu, D | 1 |
| Wegner, CJ | 1 |
| Wang, X | 1 |
| Ropelle, ER | 1 |
| Moullan, N | 1 |
| Zhang, H | 1 |
| Perino, A | 1 |
| Lemos, V | 1 |
| Kim, B | 1 |
| Park, YK | 1 |
| Piersigilli, A | 1 |
| Pham, TX | 1 |
| Yang, Y | 1 |
| Ku, CS | 1 |
| Koo, SI | 1 |
| Fomitchova, A | 1 |
| Cantó, C | 1 |
| Schoonjans, K | 1 |
| Lee, JY | 1 |
| Auwerx, J | 1 |
| Gual, P | 1 |
| Postic, C | 1 |
| Chao, KC | 1 |
| Chen, SH | 1 |
| Chang, CC | 1 |
| Lee, YC | 1 |
| Wang, CM | 1 |
| Chang, JS | 1 |
| Varela-Rey, M | 1 |
| Martínez-López, N | 1 |
| Fernández-Ramos, D | 1 |
| Embade, N | 1 |
| Calvisi, DF | 1 |
| Woodhoo, A | 1 |
| Rodríguez, J | 1 |
| Fraga, MF | 1 |
| Julve, J | 1 |
| Rodríguez-Millán, E | 1 |
| Frades, I | 1 |
| Torres, L | 1 |
| Luka, Z | 1 |
| Wagner, C | 1 |
| Esteller, M | 1 |
| Lu, SC | 1 |
| Martínez-Chantar, ML | 1 |
| Mato, JM | 1 |
| Lee, TY | 1 |
| Chan, CC | 1 |
| ESPOSITO, S | 1 |
| NICROSINI, F | 1 |
| PETRONIO, L | 1 |
| Rikans, LL | 1 |
| Arata, D | 1 |
| Cederquist, DC | 1 |
| Baker, H | 1 |
| Frank, O | 1 |
| Sorrell, MF | 1 |
| Vorberg, G | 1 |
| Henning, SM | 1 |
| McKee, RW | 1 |
| Swendseid, ME | 1 |
| Marchetti, M | 1 |
| Ottani, V | 1 |
| Puddu, P | 1 |
18 other studies available for niacinamide and Fatty Liver
| Article | Year |
|---|---|
Nicotinamide N-methyltransferase upregulation contributes to palmitate-elicited peroxisome proliferator-activated receptor transactivation in hepatocytes.
Topics: Animals; Fatty Acids; Fatty Liver; Hepatocytes; Humans; Mice; NAD; Niacinamide; Nicotinamide N-Methy | 2023 |
NAD
Topics: Animals; Atrophy; Cell Line; Chick Embryo; Dioxins; Fatty Liver; NAD; Niacinamide; Poly(ADP-ribose) | 2017 |
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Fatty Liver; Healthy Aging; In | 2018 |
Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance.
Topics: Aging; Animals; Diet, High-Fat; Fatty Liver; HEK293 Cells; Humans; Insulin Resistance; Lipid Metabol | 2018 |
NNMT activation can contribute to the development of fatty liver disease by modulating the NAD
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fatty Liver; Lipoproteins, VLDL; Liver | 2018 |
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
Topics: Alanine; Animals; Ascites; Cytokines; DNA Primers; Fatty Liver; Fibroblast Growth Factors; Microcirc | 2014 |
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Topics: Acetyltransferases; Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Diabetes Mellitus, T | 2014 |
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
Topics: Analysis of Variance; Animals; Area Under Curve; Biopsy, Needle; Diet, High-Fat; Disease Models, Ani | 2016 |
Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
Topics: Animals; Fatty Liver; Male; NAD; Niacinamide; Unfolded Protein Response | 2016 |
Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide-induced diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Dietary Supplements; Dose-Response Relationship, Drug; Fat | 2017 |
Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.
Topics: Animals; Fatty Liver; Gene Deletion; Gene Expression; Glycine N-Methyltransferase; Liver Cirrhosis; | 2010 |
Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.
Topics: Animals; Apoptosis; Disease Models, Animal; Fatty Liver; Gene Expression Regulation, Enzymologic; He | 2012 |
[The nature and prevention of hepatic steatosis caused by massive doses of nicotinamide and 6-aminonicotinamide].
Topics: 6-Aminonicotinamide; Fatty Liver; Liver Diseases; Niacin; Niacinamide; Nicotinic Acids | 1959 |
FATTY LIVERS PRODUCED IN ALBINO RATS BY EXCESS NIACIN IN HIGH FAT DIETS. II. EFFECT OF CHOLINE SUPPLEMENTS.
Topics: Alkaline Phosphatase; Blood Chemical Analysis; Body Weight; Choline; Choline Deficiency; Diet Therap | 1965 |
Nicotinic acid and alcoholism [proceedings].
Topics: Alcohol Oxidoreductases; Animals; Ethanol; Fatty Acids; Fatty Liver; Humans; Hyperlipidemias; Liver; | 1976 |
[Rational therapy of liver diseases in general practice].
Topics: Adult; Aged; Amino Acids; Chronic Disease; Drug Combinations; Fatty Liver; Female; Folic Acid; Hepat | 1976 |
Hepatic content of S-adenosylmethionine, S-adenosylhomocysteine and glutathione in rats receiving treatments modulating methyl donor availability.
Topics: Animals; Biomarkers; Choline Deficiency; Cysteine; Diet; Fatty Liver; Folic Acid Deficiency; Glutath | 1989 |
Studies on azaserine-induced fatty liver in the rat.
Topics: Acetates; Adenine Nucleotides; Adenosine Triphosphate; Animals; Azaserine; Biotin; Carbon Isotopes; | 1970 |